Regulatory News In Brief
This article was originally published in The Tan Sheet
AHPA objects to FDA food facility categories; OTC maker in China resists FDA inspection; Naturavit needs GMP consulting, FDA says; ED ingredient found in Body Basics supplement
You may also be interested in...
After most of the big pharmaceutical companies reported their full-year 2019 financial results, the second month of earnings season brings the long tail of smaller biotech companies and the generic pharmaceutical companies. There is more than one uncomfortable parallel from the former in the reports of the latter.
The HMA-EMA Big Data Task Force has offered recommendations to use data for the benefit of public health.